1. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level lumbar degenerative disc disease: results at twenty-four months
- Author
-
Jeffrey A. Goldstein, Frank P. Cammisa, Jack E. Zigler, Richard A. Balderston, Jeffrey M. Spivak, and Rick B. Delamarter
- Subjects
Adult ,Male ,medicine.medical_specialty ,Arthrodesis ,medicine.medical_treatment ,Intervertebral Disc Degeneration ,Prosthesis Design ,Statistics, Nonparametric ,Degenerative disc disease ,Disability Evaluation ,Lumbar ,Postoperative Complications ,medicine ,Device Approval ,Humans ,Orthopedics and Sports Medicine ,Prospective Studies ,Arthroplasty, Replacement ,Range of Motion, Articular ,Intervertebral Disc ,Pain Measurement ,Lumbar Vertebrae ,business.industry ,United States Food and Drug Administration ,Intervertebral disc ,General Medicine ,Prostheses and Implants ,Recovery of Function ,medicine.disease ,Arthroplasty ,United States ,Surgery ,Oswestry Disability Index ,Intervertebral disk ,medicine.anatomical_structure ,Spinal Fusion ,Treatment Outcome ,Patient Satisfaction ,Spinal fusion ,Female ,business ,Low Back Pain - Abstract
Background: Disc replacement arthroplasty previously has been shown to be an effective alternative to spine fusion for the treatment of single-level lumbar degenerative disc disease. The purpose of the present study was to determine the twenty-four-month results of a clinical trial of the ProDisc-L total disc replacement as compared with spinal fusion for the treatment of degenerative disc disease at two contiguous vertebral levels from L3 to S1. Methods: A total of 237 patients were treated in a randomized controlled trial designed as a non-inferiority study for regulatory application purposes. Blocked randomization was performed with use of a 2:1 ratio of total disc arthroplasty to circumferential arthrodesis. Evaluations, including patient self-assessments, physical and neurological examinations, and radiographic examinations, were performed preoperatively, six weeks postoperatively, and three, six, twelve, eighteen, and twenty-four months postoperatively. Results: At twenty-four months, 58.8% (eighty-seven) of 148 patients in the total disc replacement group were classified as a statistical success, compared with 47.8% (thirty-two) of sixty-seven patients in the arthrodesis group; non-inferiority was demonstrated. The mean Oswestry Disability Index in both groups significantly improved from baseline (p < 0.0001); the mean percentage improvement for the total disc replacement group was significantly better than that for the arthrodesis group (p = 0.0282). An established clinical criterion for success, a ≥15-point improvement in the Oswestry Disability Index from baseline, occurred in 73.2% (109) of 149 patients in the total disc replacement group and 59.7% (thirty-seven) of sixty-two patients in the arthrodesis group. The Short Form-36 physical component scores were significantly better for the total disc replacement group as compared with the arthrodesis group (p = 0.0141 at twenty-four months). Visual analog scale scores for satisfaction significantly favored total disc replacement from three to twenty-four months. At twenty-four months, 78.2% (111) of 142 patients in the total disc replacement group and 62.1% (thirty-six) of fifty-eight patients in the arthrodesis group responded “yes” when asked if they would have the same surgery again. Lumbar spine range of motion on radiographs averaged 7.8° at the superior disc and 6.2° at the inferior disc in patients with total disc replacement. Reduction in narcotics usage significantly favored the total disc replacement group at twenty-four months after surgery (p = 0.0020). Conclusions: Despite the relatively short duration of follow-up and design limitations, the present study suggests that two-level lumbar disc arthroplasty is an alternative to and offers clinical advantages in terms of pain relief and functional recovery in comparison with arthrodesis. Longer-term follow-up is needed to determine the risks for implant wear and/or degenerative segment changes. Level of Evidence: Therapeutic Level I. See Instructions to Authors for a complete description of levels of evidence.
- Published
- 2011